•A new point-of-care system accurately screens a
patient’s DNA for a single gene
in one hour. The shoebox-sized device from Canadian-based Spartan Bioscience analyzes cheek swabs taken from heart attack patients for a
variant, responsible for a potentially deadly reaction to the antiplatelet drug Plavix® (Clopidogrel).